If you need more lookups,
subscriptions start at $34 USD/month.
Christine Bui Location
New York, NY, US
Christine Bui Work
2020 -now Director, Medical Advisors- Team Lead for Immunology, Neuroscience, and Cardiovascular @
2025 -now DIRECTOR, US MEDICAL COMMUNCIATIONS – PIPELINE (PROFESSIONAL DEVELOPMENTAL ROTATION) @
2024 -2024 US Publications Lead – REMIBRUTINIB CSU (PROFESSIONAL DEVELOPMENT ROTATION) @
2018 -2020 Scientific Director, North America Primary Care Medical @
2017 -2018 Associate Director, US Communications, Oncology @
2016 -2017 Senior Manager, Immuno-Oncology Medical Information @
2012 -2016 Senior Manager, Cardiovascular (Stroke, DVT, VTE, Thrombosis) Medical Information @
2011 -2012 Manager (Consultant), Neuroscience Medical Information @
Christine Bui Education
Rutgers, The State University of New Jersey-New Brunswick
Christine Bui Skills
Pharmaceutical Industry
Pharmacists
Healthcare
Medical Writing
Medical Affairs
Pharmacology
Pharmacy
Neuroscience
Clinical Trials
Oncology
Anticoagulation
Cardiology
Medicine
Product Launch
Informatics
Clinical Development
Cardiovascular Disease
Atrial Fibrillation
Clinical Research
Literature
Pharmaceuticals
Literature Reviews
Medical Terminology
Medical Informatics
Launch Experience
Mature Market
Antipsychotics
Cardiovascular
Stroke
Content Management
Scientific Communications
Scientific Review
U.S. Food and Drug Administration (FDA)
Christine Bui Summary
Christine Bui, based in New York, NY, US, is currently a DIRECTOR, US MEDICAL COMMUNCIATIONS – PIPELINE (PROFESSIONAL DEVELOPMENTAL ROTATION) at Novartis. Christine Bui brings experience from previous roles at Novartis, Sanofi and Bristol-Myers Squibb. Christine Bui holds a Rutgers, The State University of New Jersey-New Brunswick. With a robust skill set that includes Pharmaceutical Industry, Pharmacists, Healthcare, Medical Writing, Medical Affairs and more. Christine Bui has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Christine Bui?
Find contact details for 700 million professionals.